◆ 会议时间：2025年2月12-15日
◆ 会议地点：美国 火奴鲁鲁

◆ 会议简介：

2025年ASTCT-CIBMTR移植与细胞冶疗大会（2025 Tandem Meetings）将于2025年2月12-15日在美国火奴鲁鲁举行。ASTCT-CIBMTR移植与细胞冶疗会议（年会）将介绍血液和骨髓移植以及细胞治疗各个领域的基础科学、转化研究和临床研究宣的最新进展，预计今年将有超过3,700名代表与会。

Tandem Meetings|ASTCT-CIBMTR移植和细胞治疗会议(BMT串连会议)，是美国移植与细胞治疗学会(ASTCT)和国际血液和骨髓移植研究中心(CIBMTR)联合举办的年度会议，首届BMT串连会议于1995年举行。未经许可禁止复制转载镜像本站任何内容—国际医学会议网（lingyuint.com）

2025 Tandem Meetings
Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR

Date:
February 12-15, 2025

Pre-conference Date: February 11, 2025
Post-conference Date: February 16, 2025

Venue:
Hawai'I Convention Center, Honolulu, HI, USA

Tandem Meetings | Transplantation and Cellular Therapy Meetings (formerly the BMT Tandem Meetings) are the combined annual meetings of the American Society for Transplantation and Cellular Therapy (ASTCT) and the Center for International Blood & Marrow Transplant Research (CIBMTR). Investigators, clinicians, laboratory technicians, clinical research professionals, nurses, pharmacists, administrators and allied health professionals benefit from the full scientific program that addresses the most timely issues in hematopoietic cell transplantation.

摘要征文投稿：

点此提交摘要>>>Submit Abstract>>>

Abstract Submission Fee

There is a $50 non-refundable abstract submission fee. Abstract submissions that have not paid the fee by Monday, October 9, 2024, will be removed from consideration.

General Submission Instructions

1. No names or titles should be included in the abstract text. Names will be automatically hidden during the abstract review process and will be automatically inserted and properly formatted upon publication.
2. Oral and Poster presentations:
   1. There will be approximately 100 abstracts selected for oral presentations during the scientific sessions during the meeting. Additional abstracts will be presented during the track conference sessions.
   2. Most other abstracts will be assigned by topic to a poster presentation.
   3. All accepted abstracts will be published as a supplement to the February 2025 issue of ASTCT's journal Transplantation and Cellular Therapy and distributed digitally prior to the 2025 Tandem Meetings of ASTCT and CIBMTR.
   4. If your abstract is accepted for oral presentation, you will be required to submit your slides for review by your session moderators AND to upload the final version of your slides before the meeting. These deadlines will be communicated to you, if accepted.
3. Required elements of this system are designated by a red (*). If you fail to enter the required data, you will be prompted to go back and correct the omission before your abstract can be submitted.
4. Verify that your abstract is correct by clicking Preview Abstract.
5. Only when you are sure that your abstract is complete and in final form, click Submit Abstract.
6. Presenting authors will be automatically informed of the unique ID numbers and passwords assigned to their abstracts. Abstracts may be viewed and modified at any time between submission and the deadline, using the assigned ID# and password.
7. Eligibility: If your abstract is accepted for either poster or oral presentations, you can expect the following:
   1. You will not be eligible for a stipend for presenting a poster or oral abstract.
   2. You will be eligible for a registration discount for the Tandem Meetings.
8. Character Count: There is a limit of 2500 characters (approximately 300 words) for the body of the abstract. Note that this character count does not include spaces or the title but does include the space allocated to tables. Figures are not included in the character count.
9. Multiple Abstracts: There are no restrictions on the number of abstracts you may submit, or the number abstracts that you may present.
10. Attached Figure: You may include up to 3 figures or images with your abstract - all figures and images must have titles. Words in that image or figure are not deducted from the total character count. Figures or images must be combined into one digital file for upload.
11. Notification: Decisions on abstract acceptance /rejection will be communicated by early December 2024. Notification will be sent by email to the presenting author listed on each abstract.
12. Abstract Corrections: All changes/edits to submitted abstracts are strictly the responsibility of the first author and must be conducted within the confines of the abstract submission portal.
13. Incomplete Abstracts: Any submitted abstract deemed incomplete within the submission system on October 10, 2024, 12:00 a.m. PT will be eliminated without further notification prior to abstracts being distributed to the 2025 Tandem Meetings of ASTCT and CIBMTR abstract review team.

注册费：

In-Person Attendee Experience

In-person attendees also receive access to all the items that attendees with digital access receive.

• Experience face-to-face interactions with in-person attendees.
• Attend sessions live, with the opportunity to ask questions of expert speakers.
• Partake in the Meet-the-Author Poster Reception featuring more than 500 posters.
• Attend receptions such as the 2025 Tandem Meetings Opening Reception and the Tandem Meetings Closing Reception.
• Meet with exhibitors, ASTCT and CIBMTR staff in the Exhibit Hall.

Digital Access Attendee Experience

• Access On-Demand Session Recordings as soon as 3 hours after the live session takes place. Sessions include Scientific Plenary and Concurrent Sessions, Oral Abstract Sessions, Honorific Lectures, Symposia and Educational Tracks.
• View On-Demand Session Recordings and complete evaluations within 30 days post meetings to receive continuing medical, nursing and pharmacy- credit.
• Connect with attendees and speakers via the mobile app and access available posters

Registration Rates & Experiences

Early Registration Deadline: December 5, 2024.

*Only available on-site. Single Day Rate does not include the ability to collect Continuing Medical Education (CME) credits. Attendees who require CME credits will need to register under the Member or Non-Member category.

**The press registration option will appear after you choose a member or non-member path in the registration system. Press registrants will be verified by the Tandem Meetings team before approval. The Tandem Meetings team will cancel any press registration if the press outlet or contact cannot be verified. 

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。